@Pledge I've missed a trick here. If Ryoncil gets a label extension then if a patient enters the Cynata trial they would be ineligible for Ryoncil. They can get Ruxolitinib and steroids, but not other therapies. So I guess that just puts us at the 1 month of extra recruiting at the 21 locations outside the US.
CYP Price at posting:
23.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)